naftopidil has been researched along with Lower Urinary Tract Symptom in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, Y; Che, X; Cui, Y; Zhang, Y; Zhou, Z | 1 |
| Dahm, P; Jung, JH; Kim, J; Kim, MH; MacDonald, R; Reddy, B | 1 |
| Gandhi, S; Hwang, EC; Jung, JH | 1 |
| Haga, K; Hirose, T; Ichihara, K; Iwasawa, A; Masumori, N; Miyao, N; Nishimura, M; Sasamura, H; Suzuki, N; Taguchi, K; Yamaguchi, Y | 1 |
| Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
| Miernik, A; Praus, F | 1 |
| Aoki, Y; Hachiya, T; Saito, T; Takahashi, S; Yamaguchi, K; Yoshikawa, T | 1 |
| Araki, M; Araki, T; Monden, K | 1 |
| Ashitomi, K; Kadekawa, K; Matayoshi, Y; Mukoyama, H; Nishijima, S; Onaga, T; Sakumoto, M; Shimabukuro, H; Shimabukuro, S; Sugaya, K | 1 |
| Baba, S; Fujita, T; Hayakawa, K; Ishiyama, H; Kimura, M; Kitano, M; Kotani, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Fujisawa, M; Haraguchi, T; Minayoshi, K; Miyake, H; Miyazaki, J; Morishita, S; Shigemura, K; Shirakawa, T; Tanaka, K; Yamada, Y | 1 |
5 review(s) available for naftopidil and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2021 |
Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Urological Agents | 2017 |
New alpha blockers to treat male lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Ejaculation; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Treatment Outcome; Urological Agents | 2018 |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents | 2019 |
4 trial(s) available for naftopidil and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: a multicenter randomized trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Ejaculation; Humans; Indoles; Kallikreins; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; Sexual Behavior; Therapeutics | 2013 |
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Brachytherapy; Humans; Indoles; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Sulfonamides; Tamsulosin | 2011 |
Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized multicenter study.
Topics: Adrenergic alpha-Antagonists; Aged; Asian People; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prostate; Prostatic Hyperplasia; Treatment Outcome; Urological Agents | 2013 |
2 other study(ies) available for naftopidil and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Tamsulosin; Treatment Outcome | 2018 |
Influence of Naftopidil on Plasma Monoamine Levels and Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Biogenic Monoamines; Dopamine; Epinephrine; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Norepinephrine; Piperazines; Prostatic Hyperplasia; Quality of Life; Serotonin | 2016 |